Klinične študije za Lupus v New York
26 študij za Lupus išče udeležence na lokacijah v New York.
Mesta v New York
Uradno besedilo študije (angleško)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50010, Brooklyn
- Sl0044 50264, Manhasset
- Sl0044 50077, New York
- in še 1
Vključevanje udeležencevFaza 3
Starost 16 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Stony Brook Internists PC, East Setauket
Vključevanje udeležencevFaza 2
Starost 18–100 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT05268289An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, New Hyde Park
- Research Site, New York
- Research Site, The Bronx
- in še 1
Vključevanje udeležencevFaza 3
Starost 5–17 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT05835310Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- in še 1
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT03816345A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- New York Medical College, Hawthorne
- NorthWell, New Hyde Park
Vključevanje udeležencevFaza 2
Starost 16–70 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07328581Transcutaneous Vagus Nerve Stimulation in SLE
- Feinstein Institutes for Medical Research, Manhasset
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06987565HEALTH Home Urinalysis Testing
- NYU Langone Health, New York
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07823478A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, New York
- Research Site, Syracuse
Vključevanje udeležencevFaza 1/2
Starost 18–70 · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
Vključevanje udeležencevFaza 1
Starost 18–74 · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07085104A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
- New York University School Of Medicine, New York
Vključevanje udeležencevFaza 4
Starost 18–75 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06875960A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Kings County Hospital Center - Brooklyn, Brooklyn
Vključevanje udeležencevOpazovalna študija
Starost 16 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Rochester, Rochester
Vključevanje udeležencevFaza 1/2
Starost 18–65 · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Icahn School of Medicine at Mount Sinai, New York
- State University of New York Upstate Medical Center (SUNY), Syracuse
Vključevanje udeležencevFaza 2
Starost 12–65 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT07053800A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Northwell Health, Great Neck
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT06570798Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- VA NY Harbor Healthcare System, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- in še 2
Vključevanje udeležencevFaza 3
Starost 55 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT05799378A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Fairport
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07260877Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 9. jul. 2026 · NCT07138898Trial of Belimumab in Early Lupus
- Feinstein Institute, Manhasset
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT03543839A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
Vključevanje udeležencevFaza 1
Starost 18–70 · Vsi spoli · Posodobljeno 5. jun. 2026 · NCT06613360A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- US08-0, Syracuse
Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci
Starost 18–70 · Vsi spoli · Posodobljeno 2. jun. 2026 · NCT06625671A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
Vključevanje udeležencevFaza 1
Starost 12–70 · Vsi spoli · Posodobljeno 22. maj 2026 · NCT06308978Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
- NYU Langone Medical Center/Hospital for Joint Diseases, New York
- Hospital for Special Surgery, New York
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18–45 · Ženske · Posodobljeno 28. apr. 2026 · NCT00198068Alnuctamab for Refractory SLE (LATTE Study)
- Icahn School of Medicine at Mount Sinai, New York
Vključevanje udeležencevFaza 1
Starost 18–60 · Vsi spoli · Posodobljeno 21. apr. 2026 · NCT07219563Lupus Landmark Study: A Prospective Registry and Biorepository
- The Feinstein Institutes for Medical Research, Manhasset
- Columbia University Medical Center, New York
- Northwell Health, New York
- in še 1
Vključevanje udeležencevOpazovalna študija
Starost 18–110 · Vsi spoli · Posodobljeno 15. apr. 2026 · NCT05934149Safety of the Herpes Zoster Subunit Vaccine in Lupus
- NYU Langone Health, New York
Vključevanje udeležencevFaza 4
Starost 18–90 · Vsi spoli · Posodobljeno 26. dec. 2025 · NCT05559671Safety and Efficacy of ONT01 in Lupus
- Hospital for Special Surgery, New York
Vključevanje udeležencevZgodnja faza 1
Starost 18 in več · Vsi spoli · Posodobljeno 20. nov. 2025 · NCT07107659Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.